【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 15
1.2 List of Figures 19
2 Introduction 20
2.1 Catalyst 20
2.2 Related Reports 21
2.3 Upcoming Related Reports 21
3 Disease Overview 22
3.1 Etiology and Pathophysiology 23
3.1.1 Etiology 23
3.1.2 Pathophysiology 25
3.2 Symptoms 27
3.3 Prognosis 28
4 Epidemiology 29
4.1 Disease Background 29
4.2 Risk Factors and Comorbidities 30
4.2.1 Infants and Young Children are at Greatest Risk for Developing Meningococcal Disease 30
4.2.2 Direct Contact and Overcrowding are the Primary Risk Factors for Infection 31
4.2.3 Exposure is Highest for Those Traveling to the African “Meningitis Belt” 32
4.3 Global Trends 33
4.3.1 US 33
4.3.2 5EU 34
4.3.3 Australia 35
4.3.4 Brazil 36
4.4 Forecast Methodology 37
4.4.1 Sources Used 39
4.4.2 Forecast Assumptions and Methods 44
4.4.3 Sources Not Used 49
4.5 Epidemiology Forecast of Meningococcal Disease (2012-2022) 50
4.5.1 Incident Cases of Meningococcal Disease 50
4.5.2 Age-Specific Incident Cases of Meningococcal Disease 53
4.5.3 Incident Cases of Meningococcal Disease By Serogroup 56
4.6 Discussion 58
4.6.1 Conclusions on Epidemiological Trends 58
4.6.2 Limitations of the Analysis 59
4.6.3 Strengths of the Analysis 60
5 Disease Management 61
5.1 Meningococcal Immunization Policy 62
5.2 US 65
5.2.1 Meningococcal Immunization Recommendations and Policies 65
5.2.2 Clinical Practice 68
5.3 France 70
5.3.1 Meningococcal Immunization Recommendations and Policies 70
5.3.2 Clinical Practice 72
5.4 Germany 74
5.4.1 Meningococcal Immunization Recommendations and Policies 74
5.4.2 Clinical Practice 75
5.5 Italy 76
5.5.1 Meningococcal Immunization Recommendations and Policies 76
5.5.2 Clinical Practice 77
5.6 Spain 78
5.6.1 Meningococcal Immunization Recommendations and Policies 78
5.6.2 Clinical Practice 79
5.7 UK 81
5.7.1 Meningococcal Immunization Recommendations and Policies 81
5.7.2 Clinical Practice 83
5.8 Japan 85
5.8.1 Meningococcal Immunization Recommendations and Policies 85
5.8.2 Clinical Practice 85
5.9 Australia 86
5.9.1 Meningococcal Immunization Recommendations and Policies 86
5.9.2 Clinical Practice 88
5.10 Brazil 90
5.10.1 Meningococcal Immunization Recommendations and Policies 90
5.10.2 Clinical Practice 91
6 Competitive Assessment 93
6.1 Overview 93
6.2 Strategic Competitor Assessment 93
6.3 Product Profiles – Major Brands 95
6.3.1 Menactra 95
6.3.2 Menveo 102
6.3.3 Nimenrix 107
6.3.4 MenHibrix 111
6.3.5 Menitorix 116
6.3.6 Meningitec 120
6.3.7 Menjugate 124
6.3.8 NeisVac-C 128
6.3.9 Menomune 132
6.3.10 Bexsero 136
7 Opportunity and Unmet Need 141
7.1 Overview 141
7.2 Unmet Needs 142
7.2.1 Unmet Need: Protection Against Serogroup B Disease 142
7.2.2 Unmet Need: A Pentavalent (MenABCWY) Vaccine 143
7.2.3 Unmet Need: More Cost-Effective Vaccines 144
7.2.4 Unmet Need: Improved Duration of Immunity in Children and Adolescents 145
7.2.5 Unmet Need: Immunogenic Infant Vaccines 147
7.2.6 Unmet Need: Improved Vaccination Coverage Rates 148
7.2.7 Unmet Need: Increased Patient Awareness and Education 149
7.3 Unmet Needs Gap Analysis 150
7.4 Opportunities 151
7.4.1 Opportunity: Broadening Serogroup Protection with New and Existing Antigen Combinations 151
7.4.2 Opportunity: Improving Immune Response Duration with Adjuvants 152
7.4.3 Opportunity: Developing More Cost-Effective Vaccines by Partnering with Manufacturers in Emerging Markets 153
8 Pipeline Assessment 154
8.1 Overview 154
8.2 Clinical Trial Mapping 155
8.2.1 Clinical Trials by Country 155
8.3 Clinical Trials by Phase and Trial Status 157
8.4 Promising Vaccines in Clinical Development 159
8.4.1 MnB rLP2086 162
8.5 Promising Vaccines in Early Clinical Development 169
8.5.1 Meninge ACYW conj. 170
8.5.2 MenABCWY 174
8.5.3 MenC conjugate 177
8.5.4 Heptavalent DTP-Hib-HepB-IPV-MenC 180
9 Current and Future Players 183
9.1 Overview 183
9.2 Trends in Corporate Strategy 187
9.3 Company Profiles 189
9.3.1 Sanofi 189
9.3.2 Novartis 193
9.3.3 GlaxoSmithKline 197
9.3.4 Baxter 200
9.3.5 Nuron Biotech 202
9.3.6 Pfizer 204
10 Market Outlook 206
10.1 Global Markets 206
10.1.1 Forecast 206
10.1.2 Drivers and Barriers – Global Issues 210
10.2 United States 214
10.2.1 Forecast 214
10.2.2 Key Events 218
10.2.3 Drivers and Barriers 219
10.3 France 223
10.3.1 Forecast 223
10.3.2 Key Events 227
10.3.3 Drivers and Barriers 228
10.4 Germany 230
10.4.1 Forecast 230
10.4.2 Key Events 233
10.4.3 Drivers and Barriers 234
10.5 Italy 236
10.5.1 Forecast 236
10.5.2 Key Events 239
10.5.3 Drivers and Barriers 240
10.6 Spain 242
10.6.1 Forecast 242
10.6.2 Key Events 245
10.6.3 Drivers and Barriers 246
10.7 United Kingdom 248
10.7.1 Forecast 248
10.7.2 Key Events 252
10.7.3 Drivers and Barriers 253
10.8 Japan 255
10.8.1 Drivers and Barriers 255
10.9 Australia 257
10.9.1 Forecast 257
10.9.2 Key Events 261
10.9.3 Drivers and Barriers 262
10.10 Brazil 264
10.10.1 Forecast 264
10.10.2 Key Events 267
10.10.3 Drivers and Barriers 268
11 Appendix 270
11.1 Bibliography 270
11.2 Abbreviations 292
11.3 Methodology 295
11.4 Forecasting Methodology 295
11.4.1 Vaccine Coverage 296
11.4.2 Vaccine Approval vs. Routine Schedule Inclusion 296
11.4.3 Vaccines Included 297
11.4.4 Key Launch Dates 298
11.4.5 General Pricing Assumptions 299
11.4.6 Individual Vaccine Assumptions 300
11.4.7 Pricing of Pipeline agents 307
11.5 Physicians and Specialists Included in this Study 308
11.6 About the Authors 312
11.6.1 Authors 312
11.6.2 Reviewers 312
11.6.3 Epidemiologists 313
11.6.4 Global Head of Healthcare 314
11.7 About GlobalData 315
11.8 Disclaimer 315
【レポート販売概要】
■ タイトル：髄膜炎菌ワクチン：世界市場（医薬品市場予測及び分析～2022）■ 英文：PharmaPoint: Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update
■ 発行日：2013年8月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161934
■ 調査対象地域：グローバル
- Gestational Diabetes：グローバル臨床試験レビューH1, 2013Gestational Diabetes Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Gestational Diabetes Global Clinical Trials Review, H1, 2013" provides data on the Gestational Diabetes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gestational Diabetes. It includes an overview of the trial numbers and their r …
- 医療機器パッケージ（包装資材）の世界市場About Medical Device Packaging Medical devices are equipment, instruments, implants, apparatus, or reagents that are used for prevention, diagnosis, and treatment of diseases through a physical process. Packaging these devices are an integral component of the Medical Device market to ensure that their sterility remains intact and the personnel handling them do not face any risks. Protection of the …
- 燃料電池商用車の世界市場2019-2023About this market The favorable incentive programs for green energy vehicles is one of the key factors expected to trigger the market’s growth in the forthcoming years. Several government bodies across the globe are leveraging innovative programs for promoting the adoption of green energy vehicles, including fuel cell vehicles. Green energy vehicles reduce air pollution significantly as they do no …
- 受託包装の世界市場2016-2020About the Contract Packaging Market The core business of contract packagers is to handle the different packaging process involved in the packaging of product manufacturing companies. Contract packagers handle any type of packaging, and they offer flexibility to manufacturers in handling complex packaging services. Contract packagers are not only involved in the packaging of products. Their service …
- Consol Energy Inc.社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Consol Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary CONSOL Energy Inc. (CONSOL Energy) is a coal and natural gas producer. The company sells its coal from the Appalachian region to electricity generators and steelmakers across the globe. It also undertakes exploration and production of natural gas, and produces Marcellus Shale, coalbed methane an …
- 熱可塑性複合材の世界市場：炭素繊維熱可塑性複合材、ガラス繊維熱可塑性複合材The thermoplastic composites market size of end products in terms of value is projected to reach around $9.9 billion by 2020 and is expected to grow at a CAGR of 6.5% between 2015 and 2020. Major market segments which are expected to drive this market are transportation, aerospace & defense, electrical & electronic, and consumer goods. Agreements & partnerships and expansion of production capacity …
- 商業用水処理装置の世界市場2016-2020About Commercial Water Treatment Equipment The commercial water treatment equipment is used in schools, offices, hospitals, restaurants, hotels, construction sites, laboratories, and organizations. The stringent government regulations and growing health concerns are positively impacting the commercial water treatment market. In addition, increased construction activities that require water treatme …
- バイオマーカーの世界市場予測（～2021年）：安全性マーカー、予測マーカー、代替マーカー、薬力学マーカー、予後マーカーThe global biomarkers market is estimated to reach USD 53.34 billion by 2021 from USD 27.95 billion in 2016, at a CAGR of 13.8% from 2016 to 2021.Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker …
- 世界の沸石（Zeolite）市場動向（2014-2018）TechNavio's analysts forecast the Global Zeolite market to grow at a CAGR of 7.33 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased use of zeolites in catalysis and petroleum refining. The Global Zeolite market has also been witnessing the trend of increase in production capacities. However, the intense competition leading to price wars c …
- TPMS（タイヤ空気圧監視システム）の世界市場2015-2019About TPMS TPMS is an electronic system, designed to provide real-time information about tire pressure by monitoring the air pressure inside the tires. TPMS warns the driver about the number of underinflated tires. TPMS is classified into two categories: direct TPMS and indirect TPMS. Direct TPMS provides real-time information of the tire pressure using pressure monitoring sensors in the tires. As …
- 企業向けサイバーセキュリティソリューションの世界市場About Enterprise Cyber Security Cyber threats are attempts to disrupt or damage IT systems, through the internet, and access critical information using spyware, malware, and phishing. Cyber security solutions help enterprises monitor, detect, report, and counter cyber threats to maintain the confidentiality of IT systems. Increased internet penetration and increased usage of mobile devices and app …
- 2014年戦略提言：Salmonella診断検査市場The report presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Salmonella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - P …
- Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Refractive Surgery Devices market in the BRICS countries. The report provides value ($m), volume (units) and average price ($ …
- 麻酔デバイスの世界市場：麻酔器、麻酔情報システム、麻酔モニタリング装置Anesthesia machines are used by anesthesiologists to support the administration of anesthetic and other medical gases such as nitrous oxide. The most commonly used device is the continuous-flow anesthetic machine, which provides a continuous flow of air, containing a regulated supply of gas. Modern anesthesia devices include monitor and touch screen display, which help in monitoring heartbeat. Tec …
- インダストリアルIoTの世界市場予測（～2020）The Industrial Internet of Things (IIoT) market is expected to reach USD 151.01 Billion by 2020. IIoT is expected to generate many opportunities for various sectors such as manufacturing, metals & mining, and healthcare. It is likely to change the way production processes are executed and would benefit different businesses by enabling optimum utilization of resources, smart decision-making capabil …
